课题基金 / 基金详情

EFFICACY AND SAFETY OF COPOLYMER I IN PATIENTS WITH MULTIPLE SCLEROSIS

EFFICACY AND SAFETY OF COPOLYMER I IN PATIENTS WITH MULTIPLE SCLEROSIS
共聚物 I 对多发性硬化症患者的功效和安全性
批准号：
3788653
负责人：
Jerry Saul Wolinsky
金额：
$0.0万
依托单位：
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3788653
关键词：
clinical trials copolymer drug screening /evaluation human subject human therapy evaluation injection /infusion multiple sclerosis nervous system disorder chemotherapy relapse /recurrence synthetic peptide

项目摘要

项目成果

Jerry Saul Wolinsky的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a double-blind, placebo controlled multicenter Phase III study. The purpose of the study is to determine whether 20 mg of Copolymer I administered by subcutaneous injection daily for 24 months to patients with relapsing-remitting multiple sclerosis reduces the number of relapses as compared to placebo. It also compares the safety and tolerance of Copolymer I and placebo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AVONEX IN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
HU23F2G IN ACUTE EXACERBATIONS OF MULTIPLE SCLEROSIS
AVONEX IN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
COPAXONE IN PATIENTS WITH MULTIPLE SCLEROSIS--OPEN LABEL STUDY
海外基金